MULTICENTER, DOUBLE-BLIND, RANDOMIZED, DETERMINATION STUDY OF THE RANGE OF DOSE TO COMPARE THE SAFETY AND ACTIVITY OF MK-0518 PLUS TENOFOVIR AND LAMIVUDINE (3TC) COMPARED TO EFAVIRENZ PLUS TENOFOVIR AND LAMIVUDINE (3TC) IN PATIENTS INFECTED WITH HIV NOT SUBMITTED TO ART- EXTENSION STUDY

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2008
This article has no abstract
Epistemonikos ID: 340e7d5b12aa33b9b3b6037733683c8157d2fab7
First added on: Apr 16, 2025